Eisenhower Health is the first hospital in Southern California to offer a new lung valve treatment for patients with severe COPD/emphysema. Recently approve by the FDA under their “Breakthrough Devices” status, the Zephyr Endobronchial Valve treatment represents a major advancement because it is the first minimally invasive procedure to help emphysema sufferers breathe easier without major surgery.
People with severe emphysema may breathe better after a minimally invasive procedure that places valves in the airways leading to diseased portions of their lungs, according to a randomize; so control trial publish online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
The first multicenter randomize
In Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM),” European researchers report results from the first multicenter randomize; so control trial comparing the therapeutic approach develop by Pulmonx Corp. to standard of care. The one-way Zephyr valve keeps air from entering disease regions of the lung; hence allowing healthier regions to expand and function better.
Done through a simple bronchoscopy, the valves improve patients‘ quality of life by allowing them to breathe easier; so be less short of breath, and be more active and energetic. They are very excite to offer this new treatment option,” says Justin Thomas, MD, who is Board Certified in Internal Medicine; so Pulmonary Disease; so Critical Care Medicine, and Interventional Pulmonary Medicine and the Director of the Bronchoscopy Laboratory, Eisenhower Health.
Emphysema patients are often in poor physical condition; so struggling with each breath despite medication therapy. Before the Zephyr Valves the only options for relief were highly invasive treatments including lung surgeries. Being able to offer this minimally invasive procedure has the potential to improve the quality of life for many emphysema sufferers in the Coachella Valley and beyond.
Life threatening lung disease
Emphysema is a progressive and life-threatening lung disease; also a severe form of chronic pulmonary obstructive disease (COPD). There is no cure and patients live with severe shortness of breath; so that keeps them from doing simple daily activities like walking or taking a shower without pausing to catch their breath or resting. This extreme shortness of breath is cause; so when air becomes trap in parts of the lung that are damage by the disease.
During this one-time, short procedure, on average, a physician places four tiny valves; so in the airways to block off the damage areas of the lungs so air no longer gets trap there. This allows the healthier parts of the lungs to expand and relieves the pressure on the diaphragm; which decreases shortness of breath and makes breathing easier.
The Zephyr Valves were approve by the FDA in July 2018. Since 2007, more than 15,000 patients have treat with The Zephyr Valve worldwide. Zephyr Valve treatment is include in emphysema treatment recommendations issue by leading health organizations worldwide, including the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and the UK’s National Institute for Health and Care Excellence (NICE).